Posted by Michael Wonder on 30 Jul 2018
New diabetes and hepatitis C medications available to patients this week
30 July 2018 - The Australian Government will help improve the lives of those living with diabetes and hepatitis C by making two treatments more affordable, helping patients save thousands of dollars a year.
The Turnbull Government will help improve the lives of those living with diabetes and hepatitis C by making two treatments more affordable, helping patients save thousands of dollars a year.
In excess of 170,000 Australians, who face the many challenges and risks of living with the hepatitis C, are expected to benefit from the listing of Maviret on the Pharmaceutical Benefits Scheme from August 1.
